The University of Lübeck is a research university in Lübeck, Northern Germany which focuses almost entirely on medicine and sciences with applications in medicine.

During the past decade, University of Lübeck conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Lübeck" #1 sponsor was "University of Luebeck" with 3 trials, followed by "AKARI Therapeutics" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored and "Dr. Rebecca Schule" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Lübeck" #1 collaborator was "Federal Ministry of Health, Germany" with 1 trials as a collaborator, "German Center for Neurodegenerative Diseases (DZNE)" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Martin-Luther-Universität Halle-Wittenberg" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Lübeck" are "Acute Graft Rejection" (1 trials), "Bullous Pemphigoid (BP)" (1 trials), "Cardiovascular Diseases" (1 trials), "Coronary Artery Disease" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "University of Lübeck" in a lesser frequency.

Most popular intervention types in "University of Lübeck" are "Other" (4 trials), "Device" (3 trials), "Behavioral" (2 trials), "Diagnostic Test" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Brief intervention, Motivational Interviewing, Expert System" (1 trials), "Clinical rating scale to measure disease severity and progression" (1 trials), "DuraGraft" (1 trials), "Educational programme for all nurses" (1 trials) and "Facultative train-the-trainer module for key nurses" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Lübeck" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Lübeck". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Lübeck, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Lübeck, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".